This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) for therapeutic drugs. Its unique structure, featuring a trifluoroethyl group, makes it valuable in medicinal chemistry for enhancing the metabolic stability and bioavailability of drug candidates. It is often employed in the production of compounds targeting central nervous system disorders, such as antidepressants and antipsychotics. Additionally, it serves as a key building block in organic synthesis for creating complex molecules with potential applications in drug discovery and development. Its trifluoroethyl moiety is particularly useful in modifying the pharmacokinetic properties of drug molecules, improving their efficacy and safety profiles.